Medihealth Lifesciences ( India ) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.92 M
as on 15-05-2024
- Revenue 40.28%
(FY 2022)
- Profit 87.16%
(FY 2022)
- Ebitda 30.53%
(FY 2022)
- Net Worth 128.22%
(FY 2022)
- Total Assets 60.90%
(FY 2022)
About Medihealth Lifesciences ( India )
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.92 M.
Brij Sharma, Manju Jian, Alok Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232RJ2009PTC028139
- Company No.
028139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medihealth Lifesciences ( India )?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brij Sharma  | Director | 19-Jan-2009 | Current |
| Manju Jian | Director | 19-Jan-2009 | Current |
| Alok Sharma | Director | 19-Jan-2009 | Current |
| Devika Jain | Director | 19-Jan-2009 | Current |
Financial Performance and Corporate Structure Insights of Medihealth Lifesciences ( India ).
Medihealth Lifesciences ( India ) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.28% increase. The company also saw a substantial improvement in profitability, with a 87.16% increase in profit. The company's net worth Soared by an impressive increase of 128.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medihealth Lifesciences ( India )?
In 2020, Medihealth Lifesciences ( India ) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Jun 2012 | ₹5.92 M | Open |
How Many Employees Work at Medihealth Lifesciences ( India )?
Unlock and access historical data on people associated with Medihealth Lifesciences ( India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medihealth Lifesciences ( India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medihealth Lifesciences ( India )'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
